2019-06-20

Press releases regulatory

2cureX appoints Dr. Med. Henrik Harling as Chief Medical Officer

2cureX AB (NASDAQ: 2CUREX), a clinical-stage company that has developed the IndiTreat® test allowing individualization of cancer treatment, hereby announces...

2019-05-28

Press releases regulatory

Communique from the Annual General Meeting in 2cureX AB (publ)

Today, on May 28th, 2019, the Annual General Meeting (“AGM”) was held in 2cureX AB (publ). Below follows a summary...

2019-05-28

Press releases regulatory

Significantly oversubscribed rights issue in 2cureX AB

On May 23, 2019, the subscription period ended in 2cureX AB’s (“2cureX”) rights issue prior to the market launch of...

2019-05-09

Press releases regulatory

Today, the subscription period starts in 2cureX’s rights issue

Today, on the 9th of May 2019, the subscription period in 2cureX AB’s (“2cureX”) rights issue prior to the market...

2019-05-08

Press releases

2cureX publishes memorandum ahead of the rights issue

2cureX AB (“2cureX”) hereby publishes the investment memorandum ahead of the company’s rights issue, in which the subscription period starts...

2019-05-08

Press releases regulatory

2cureX publishes interim report for the first quarter of 2019

2cureX AB (“2cureX”) hereby publishes the interim report for the first quarter of 2019. The interim report is available as...